摘要
胰岛β细胞量(βcell mass)减少是1型或2型糖尿病的重要特征之一,确切检测和评估β细胞量具有重要意义。目前,胰腺组织学定量,分离后胰岛的定量和β细胞新生、增殖以及死亡的检测主要用于体外胰岛β细胞量测定研究;体内则利用β细胞分泌功能指标、正电子发射断层扫描(PET)的影像学技术进行间接评估,具有重要的应用价值。
Islet β cell loss plays an important role in the pathogenesis of type 1 and type 2 diabetes. Therefore, it is essential to measure or evaluate the β cell mass. Pancreas immunohistochemistry study, measurement of functional β cell mass after islet isolation, and β cell neogenesis, proliferation and cell death are mainly used in in vitro study. Islet β cell functional tests and positron emission tomography (PET) technique are the potential methods to evaluate β cell mass in vivo.
出处
《中华内分泌代谢杂志》
CAS
CSCD
北大核心
2008年第1期88-90,共3页
Chinese Journal of Endocrinology and Metabolism